Literature DB >> 22702487

Cooking up tolerance: has a new recipe been created?

L S Kean, B R Blazar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22702487      PMCID： PMC3482492          DOI： 10.1111/j.1600-6143.2012.04154.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  9 in total

Review 1.  Opportunistic infections: an update.

Authors:  Hansjakob Furrer; Christoph Fux
Journal:  J HIV Ther       Date:  2002-02

2.  Immunologic tolerance to renal allografts after bone marrow transplants from the same donors.

Authors:  M H Sayegh; N A Fine; J L Smith; H G Rennke; E L Milford; N L Tilney
Journal:  Ann Intern Med       Date:  1991-06-01       Impact factor: 25.391

3.  Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.

Authors:  Joseph Leventhal; Michael Abecassis; Joshua Miller; Lorenzo Gallon; Kadiyala Ravindra; David J Tollerud; Bradley King; Mary Jane Elliott; Geoffrey Herzig; Roger Herzig; Suzanne T Ildstad
Journal:  Sci Transl Med       Date:  2012-03-07       Impact factor: 17.956

Review 4.  Haploidentical hematopoietic transplantation: current status and future perspectives.

Authors:  Yair Reisner; David Hagin; Massimo F Martelli
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

5.  Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.

Authors:  Mauro Di Ianni; Franca Falzetti; Alessandra Carotti; Adelmo Terenzi; Flora Castellino; Elisabetta Bonifacio; Beatrice Del Papa; Tiziana Zei; Roberta Iacucci Ostini; Debora Cecchini; Teresa Aloisi; Katia Perruccio; Loredana Ruggeri; Chiara Balucani; Antonio Pierini; Paolo Sportoletti; Cynthia Aristei; Brunangelo Falini; Yair Reisner; Andrea Velardi; Franco Aversa; Massimo F Martelli
Journal:  Blood       Date:  2011-02-03       Impact factor: 22.113

6.  Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

Authors:  Franco Aversa; Adelmo Terenzi; Antonio Tabilio; Franca Falzetti; Alessandra Carotti; Stelvio Ballanti; Rita Felicini; Flavio Falcinelli; Andrea Velardi; Loredana Ruggeri; Teresa Aloisi; Jean Pierre Saab; Antonella Santucci; Katia Perruccio; Maria Paola Martelli; Cristina Mecucci; Yair Reisner; Massimo F Martelli
Journal:  J Clin Oncol       Date:  2005-03-07       Impact factor: 44.544

7.  Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

Authors:  N Rachamim; J Gan; H Segall; R Krauthgamer; H Marcus; A Berrebi; M Martelli; Y Reisner
Journal:  Transplantation       Date:  1998-05-27       Impact factor: 4.939

8.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

9.  Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells.

Authors:  C L Kaufman; Y L Colson; S M Wren; S Watkins; R L Simmons; S T Ildstad
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113
  9 in total
  1 in total

Review 1.  Induction of tolerance through mixed chimerism.

Authors:  David H Sachs; Tatsuo Kawai; Megan Sykes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.